B.R.Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-10-2024
- Paid Up Capital ₹ 0.30 M
as on 30-10-2024
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.56 Cr
as on 30-10-2024
- Revenue 33.77%
(FY 2023)
- Profit 51.49%
(FY 2023)
- Ebitda 275.34%
(FY 2023)
- Net Worth 18.23%
(FY 2023)
- Total Assets 13.93%
(FY 2023)
About B.R.Diagnostic Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.56 Cr.
Jayanti Sen, Phani Roy, and Tapas Sen serve as directors at the Company.
- CIN/LLPIN
U85195WB2001PTC093431
- Company No.
093431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Malda, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at B.R.Diagnostic Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayanti Sen  | Director | 16-Oct-2015 | Current |
| Phani Roy | Director | 10-Jul-2001 | Current |
| Tapas Sen | Director | 10-Jul-2001 | Current |
Financial of B.R.Diagnostic Centre.
B.R.Diagnostic Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.77% increase. The company also saw a substantial improvement in profitability, with a 51.49% increase in profit. The company's net worth Soared by an impressive increase of 18.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B.R.Diagnostic Centre?
Unlock access to B.R.Diagnostic Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 06 Mar 2024 | ₹2.65 M | Open |
Axis Bank Limited Creation Date: 06 Nov 2019 | ₹2.50 M | Open |
State Bank Of India Creation Date: 28 Nov 2008 | ₹1.04 Cr | Open |
How Many Employees Work at B.R.Diagnostic Centre?
B.R.Diagnostic Centre has a workforce of 26 employees as of Oct 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B.R.Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B.R.Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
